ArticleBMC medicine2022

Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.

Takayuki Ueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.